Delivery Order SPE2DB22D1202-SPE2DB23FUET2
- Not listed
- This is a $1,010.76 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lidocaine-Prilocaine Cream, a topical anesthetic used for medical purposes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,898.94 firm fixed price delivery order contract to provide 4564029946 Lidocaine-Prilocaine Cream 5GM. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Lidocaine-Prilocaine creams. The $1,995.76 firm fixed-price contract has an ultimate completion date of December 29, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, valued at up to $999,999,999.00 and...
- This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lidocaine-Prilocaine Cream, a topical anesthetic medication, with a ceiling value of $8,001.33 and a completion date of June 14, 2023. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen is a for-profit organization and a registered vendor in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,126.27 fixed-price delivery order is for the supply of Lidocaine-Prilocaine Cream, a topical anesthetic medication. The contract has a completion date of May 25, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,574.88 firm fixed price delivery order is for the supply of 30 gram tubes of Lidocaine-Prilocaine Cream, a topical anesthetic medication. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,151.10 firm fixed-price delivery order is for the supply of Lidocaine-Prilocaine Cream, a topical anesthetic medication. The contract has a period of performance through March 14, 2023 and was awarded on March 13, 2023. This award is under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of medical supplies, specifically Lidocaine-HC 3-0.5% cream kits. The award, valued at $1,686.58, is a delivery order with a firm fixed price contract type, and the ultimate completion date is December 27, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $2,824.37, is for the delivery of a specific medical product - Lidocaine HCL 2% 200 mg/10 mL. The contract is a firm fixed-price Delivery Order with a completion date of June 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine Hydrochloride, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,436.93, has a completion date of February 16, 2024 and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FUET2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., is for the delivery of Lidocaine-Prilocaine Cream 30GM to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,421.45 and an ultimate completion date of September 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through December 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. Additionally, Amerisourcebergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/26/23 |